Company profile RVPH
After 39 days of this quarter the interest is at 71.0. Based on that we can calculate that during remaining 52 days it will total up to 166.0. Reviva Pharmaceuticals expected interest is significantly higher compared to same quarter last year (+191.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 34 | 119 250.0% QoQ | 166 39.5% QoQ | 96 -42.2% QoQ |
| 2020 | 193 467.6% YoY 101.0% QoQ | 88 -26.1% YoY -54.4% QoQ | 76 -54.2% YoY -13.6% QoQ | 72 -25.0% YoY -5.3% QoQ |
| 2021 | 162 -16.1% YoY 125.0% QoQ | 271 208.0% YoY 67.3% QoQ | 155 103.9% YoY -42.8% QoQ | 209 190.3% YoY 34.8% QoQ |
| 2022 | 159 -1.9% YoY -23.9% QoQ | 98 -63.8% YoY -38.4% QoQ | 164 5.8% YoY 67.3% QoQ | 203 -2.9% YoY 23.8% QoQ |
| 2023 | 57 -64.2% YoY -71.9% QoQ | 112 14.3% YoY 96.5% QoQ | 172 4.9% YoY 53.6% QoQ | 261 28.6% YoY 51.7% QoQ |
| 2024 | 71 24.6% YoY -72.8% QoQ | - | - | - |
The average 5 years interest of Reviva Pharmaceuticals was 11.26 per week. The last year interest of Reviva Pharmaceuticals compared to the last 5 years has changed by 5.24%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 22.8%.
After 39 days of this quarter the interest is at 134.0. Based on that we can calculate that during remaining 52 days it will total up to 313.0. brilaroxazine expected interest is significantly higher compared to same quarter last year (+92.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 86 inf% QoQ | 182 111.6% QoQ | 20 -89.0% QoQ |
| 2020 | 41 inf% YoY 105.0% QoQ | 65 -24.4% YoY 58.5% QoQ | 20 -89.0% YoY -69.2% QoQ | 53 165.0% YoY 165.0% QoQ |
| 2021 | 108 163.4% YoY 103.8% QoQ | 75 15.4% YoY -30.6% QoQ | 145 625.0% YoY 93.3% QoQ | 96 81.1% YoY -33.8% QoQ |
| 2022 | 71 -34.3% YoY -26.0% QoQ | 83 10.7% YoY 16.9% QoQ | 149 2.8% YoY 79.5% QoQ | 50 -47.9% YoY -66.4% QoQ |
| 2023 | 163 129.6% YoY 226.0% QoQ | 69 -16.9% YoY -57.7% QoQ | 116 -22.1% YoY 68.1% QoQ | 228 356.0% YoY 96.6% QoQ |
| 2024 | 134 -17.8% YoY -41.2% QoQ | - | - | - |
The average 5 years interest of brilaroxazine was 7.49 per week. The last year interest of brilaroxazine compared to the last 5 years has changed by 61.28%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 104.75%.
There is not enough data for RP5063 to provide analysis
There is not enough data for RP5063 to provide correlation calculation
There is not enough data for RP5063 to provide analysis
After 39 days of this quarter the interest is at 107.0. Based on that we can calculate that during remaining 52 days it will total up to 250.0. Phase III clinical trials expected interest is significantly higher compared to previous quarter (+82.5%) and same quarter last year (+71.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 91 | 167 83.5% QoQ | 25 -85.0% QoQ | 251 904.0% QoQ |
| 2020 | 206 126.4% YoY -17.9% QoQ | 165 -1.2% YoY -19.9% QoQ | 131 424.0% YoY -20.6% QoQ | 289 15.1% YoY 120.6% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 83 -49.7% YoY inf% QoQ | 367 180.2% YoY 342.2% QoQ | 210 -27.3% YoY -42.8% QoQ |
| 2022 | 79 inf% YoY -62.4% QoQ | 182 119.3% YoY 130.4% QoQ | 15 -95.9% YoY -91.8% QoQ | 101 -51.9% YoY 573.3% QoQ |
| 2023 | 146 84.8% YoY 44.6% QoQ | 164 -9.9% YoY 12.3% QoQ | 55 266.7% YoY -66.5% QoQ | 137 35.6% YoY 149.1% QoQ |
| 2024 | 107 -26.7% YoY -21.9% QoQ | - | - | - |
The average 5 years interest of Phase III clinical trials was 11.38 per week. The last year interest of Phase III clinical trials compared to the last 5 years has changed by -4.22%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -9.62%.
After 39 days of this quarter the interest is at 243.0. Based on that we can calculate that during remaining 52 days it will total up to 567.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 318 | 551 73.3% QoQ | 377 -31.6% QoQ | 537 42.4% QoQ |
| 2020 | 524 64.8% YoY -2.4% QoQ | 557 1.1% YoY 6.3% QoQ | 432 14.6% YoY -22.4% QoQ | 564 5.0% YoY 30.6% QoQ |
| 2021 | 410 -21.8% YoY -27.3% QoQ | 551 -1.1% YoY 34.4% QoQ | 362 -16.2% YoY -34.3% QoQ | 528 -6.4% YoY 45.9% QoQ |
| 2022 | 623 52.0% YoY 18.0% QoQ | 780 41.6% YoY 25.2% QoQ | 447 23.5% YoY -42.7% QoQ | 691 30.9% YoY 54.6% QoQ |
| 2023 | 623 0.0% YoY -9.8% QoQ | 747 -4.2% YoY 19.9% QoQ | 497 11.2% YoY -33.5% QoQ | 782 13.2% YoY 57.3% QoQ |
| 2024 | 243 -61.0% YoY -68.9% QoQ | - | - | - |
The average 5 years interest of schizophrenia treatment was 42.7 per week. The last year interest of schizophrenia treatment compared to the last 5 years has changed by 19.58%. The interest for schizophrenia treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 34.97%.
After 39 days of this quarter the interest is at 225.0. Based on that we can calculate that during remaining 52 days it will total up to 525.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 351 | 562 60.1% QoQ | 459 -18.3% QoQ | 610 32.9% QoQ |
| 2020 | 566 61.3% YoY -7.2% QoQ | 596 6.0% YoY 5.3% QoQ | 476 3.7% YoY -20.1% QoQ | 600 -1.6% YoY 26.1% QoQ |
| 2021 | 549 -3.0% YoY -8.5% QoQ | 556 -6.7% YoY 1.3% QoQ | 435 -8.6% YoY -21.8% QoQ | 556 -7.3% YoY 27.8% QoQ |
| 2022 | 691 25.9% YoY 24.3% QoQ | 784 41.0% YoY 13.5% QoQ | 538 23.7% YoY -31.4% QoQ | 752 35.3% YoY 39.8% QoQ |
| 2023 | 717 3.8% YoY -4.7% QoQ | 716 -8.7% YoY -0.1% QoQ | 570 5.9% YoY -20.4% QoQ | 829 10.2% YoY 45.4% QoQ |
| 2024 | 225 -68.6% YoY -72.9% QoQ | - | - | - |
The average 5 years interest of bipolar disorder treatment was 46.51 per week. The last year interest of bipolar disorder treatment compared to the last 5 years has changed by 15.29%. The interest for bipolar disorder treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 26.22%.
After 39 days of this quarter the interest is at 112.0. Based on that we can calculate that during remaining 52 days it will total up to 261.0. major depressive disorder treatment expected interest is significantly lower compared to previous quarter (-63.3%) and same quarter last year (-49.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 257 | 265 3.1% QoQ | 216 -18.5% QoQ | 319 47.7% QoQ |
| 2020 | 284 10.5% YoY -11.0% QoQ | 322 21.5% YoY 13.4% QoQ | 186 -13.9% YoY -42.2% QoQ | 430 34.8% YoY 131.2% QoQ |
| 2021 | 367 29.2% YoY -14.7% QoQ | 327 1.6% YoY -10.9% QoQ | 253 36.0% YoY -22.6% QoQ | 389 -9.5% YoY 53.8% QoQ |
| 2022 | 507 38.1% YoY 30.3% QoQ | 591 80.7% YoY 16.6% QoQ | 307 21.3% YoY -48.1% QoQ | 612 57.3% YoY 99.3% QoQ |
| 2023 | 514 1.4% YoY -16.0% QoQ | 604 2.2% YoY 17.5% QoQ | 382 24.4% YoY -36.8% QoQ | 712 16.3% YoY 86.4% QoQ |
| 2024 | 112 -78.2% YoY -84.3% QoQ | - | - | - |
The average 5 years interest of major depressive disorder treatment was 30.48 per week. The last year interest of major depressive disorder treatment compared to the last 5 years has changed by 35.14%. The interest for major depressive disorder treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 89.38%.
There is not enough data for attention-deficit/hyperactivity disorder treatment to provide analysis
There is not enough data for attention-deficit/hyperactivity disorder treatment to provide correlation calculation
There is not enough data for attention-deficit/hyperactivity disorder treatment to provide analysis
There is not enough data for behavioral and psychotic symptoms of dementia treatment to provide analysis
There is not enough data for behavioral and psychotic symptoms of dementia treatment to provide correlation calculation
There is not enough data for behavioral and psychotic symptoms of dementia treatment to provide analysis
After 34 days of this quarter the interest is at 159.0. Based on that we can calculate that during remaining 58 days it will total up to 430.0. Alzheimer's disease treatment expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+inf%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 177 |
| 2019 | 176 -0.6% QoQ | 151 -14.2% QoQ | 237 57.0% QoQ | 286 61.6% YoY 20.7% QoQ |
| 2020 | 277 57.4% YoY -3.1% QoQ | 184 21.9% YoY -33.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 159 inf% YoY inf% QoQ |
The average 5 years interest of Alzheimer's disease treatment was 6.31 per week. The last year interest of Alzheimer's disease treatment compared to the last 5 years has changed by -51.51%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -80.88%.
Google Trends for Parkinson's disease psychosis treatment
Not enough data for reliable calculations!
There is not enough data for Parkinson's disease psychosis treatment to provide analysis
There is not enough data for Parkinson's disease psychosis treatment to provide correlation calculation
There is not enough data for Parkinson's disease psychosis treatment to provide analysis
After 39 days of this quarter the interest is at 134.0. Based on that we can calculate that during remaining 52 days it will total up to 313.0. pulmonary arterial hypertension treatment expected interest is significantly higher compared to previous quarter (+117.4%) and same quarter last year (+112.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 68 | 33 -51.5% QoQ | 158 378.8% QoQ | 109 -31.0% QoQ |
| 2020 | 131 92.6% YoY 20.2% QoQ | 66 100.0% YoY -49.6% QoQ | 179 13.3% YoY 171.2% QoQ | 140 28.4% YoY -21.8% QoQ |
| 2021 | 29 -77.9% YoY -79.3% QoQ | 98 48.5% YoY 237.9% QoQ | 114 -36.3% YoY 16.3% QoQ | 45 -67.9% YoY -60.5% QoQ |
| 2022 | 59 103.4% YoY 31.1% QoQ | 11 -88.8% YoY -81.4% QoQ | 44 -61.4% YoY 300.0% QoQ | 99 120.0% YoY 125.0% QoQ |
| 2023 | 147 149.2% YoY 48.5% QoQ | 108 881.8% YoY -26.5% QoQ | 158 259.1% YoY 46.3% QoQ | 144 45.5% YoY -8.9% QoQ |
| 2024 | 134 -8.8% YoY -6.9% QoQ | - | - | - |
The average 5 years interest of pulmonary arterial hypertension treatment was 7.95 per week. The last year interest of pulmonary arterial hypertension treatment compared to the last 5 years has changed by 48.3%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 50.57%.
After 39 days of this quarter the interest is at 78.0. Based on that we can calculate that during remaining 52 days it will total up to 182.0. idiopathic pulmonary fibrosis treatment expected interest is significantly lower compared to previous quarter (-46.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 118 | 135 14.4% QoQ | 101 -25.2% QoQ | 131 29.7% QoQ |
| 2020 | 152 28.8% YoY 16.0% QoQ | 147 8.9% YoY -3.3% QoQ | 289 186.1% YoY 96.6% QoQ | 98 -25.2% YoY -66.1% QoQ |
| 2021 | 182 19.7% YoY 85.7% QoQ | 259 76.2% YoY 42.3% QoQ | 280 -3.1% YoY 8.1% QoQ | 126 28.6% YoY -55.0% QoQ |
| 2022 | 195 7.1% YoY 54.8% QoQ | 119 -54.1% YoY -39.0% QoQ | 71 -74.6% YoY -40.3% QoQ | 101 -19.8% YoY 42.3% QoQ |
| 2023 | 184 -5.6% YoY 82.2% QoQ | 239 100.8% YoY 29.9% QoQ | 216 204.2% YoY -9.6% QoQ | 339 235.6% YoY 56.9% QoQ |
| 2024 | 78 -57.6% YoY -77.0% QoQ | - | - | - |
The average 5 years interest of idiopathic pulmonary fibrosis treatment was 13.64 per week. The last year interest of idiopathic pulmonary fibrosis treatment compared to the last 5 years has changed by 34.38%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 84.04%.
There is not enough data for RP1208 to provide analysis
There is not enough data for RP1208 to provide correlation calculation
There is not enough data for RP1208 to provide analysis
There is not enough data for pre-clinical development to provide analysis
There is not enough data for pre-clinical development to provide correlation calculation
There is not enough data for pre-clinical development to provide analysis
After 39 days of this quarter the interest is at 272.0. Based on that we can calculate that during remaining 52 days it will total up to 635.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 502 | 698 39.0% QoQ | 610 -12.6% QoQ | 700 14.8% QoQ |
| 2020 | 655 30.5% YoY -6.4% QoQ | 584 -16.3% YoY -10.8% QoQ | 616 1.0% YoY 5.5% QoQ | 663 -5.3% YoY 7.6% QoQ |
| 2021 | 649 -0.9% YoY -2.1% QoQ | 781 33.7% YoY 20.3% QoQ | 692 12.3% YoY -11.4% QoQ | 796 20.1% YoY 15.0% QoQ |
| 2022 | 826 27.3% YoY 3.8% QoQ | 847 8.5% YoY 2.5% QoQ | 755 9.1% YoY -10.9% QoQ | 802 0.8% YoY 6.2% QoQ |
| 2023 | 803 -2.8% YoY 0.1% QoQ | 760 -10.3% YoY -5.4% QoQ | 661 -12.5% YoY -13.0% QoQ | 835 4.1% YoY 26.3% QoQ |
| 2024 | 272 -66.1% YoY -67.4% QoQ | - | - | - |
The average 5 years interest of depression treatment was 55.58 per week. The last year interest of depression treatment compared to the last 5 years has changed by 3.22%. The interest for depression treatment is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 7.27%.
After 39 days of this quarter the interest is at 309.0. Based on that we can calculate that during remaining 52 days it will total up to 721.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 446 | 557 24.9% QoQ | 536 -3.8% QoQ | 543 1.3% QoQ |
| 2020 | 618 38.6% YoY 13.8% QoQ | 605 8.6% YoY -2.1% QoQ | 575 7.3% YoY -5.0% QoQ | 607 11.8% YoY 5.6% QoQ |
| 2021 | 606 -1.9% YoY -0.2% QoQ | 627 3.6% YoY 3.5% QoQ | 564 -1.9% YoY -10.0% QoQ | 613 1.0% YoY 8.7% QoQ |
| 2022 | 829 36.8% YoY 35.2% QoQ | 753 20.1% YoY -9.2% QoQ | 689 22.2% YoY -8.5% QoQ | 799 30.3% YoY 16.0% QoQ |
| 2023 | 867 4.6% YoY 8.5% QoQ | 837 11.2% YoY -3.5% QoQ | 749 8.7% YoY -10.5% QoQ | 907 13.5% YoY 21.1% QoQ |
| 2024 | 309 -64.4% YoY -65.9% QoQ | - | - | - |
The average 5 years interest of obesity treatment was 52.25 per week. The last year interest of obesity treatment compared to the last 5 years has changed by 21.78%. The interest for obesity treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 43.38%.